SCHEMBL4373652

SCHEMBL4373652

CC1CCCC(CN(C)C)C1(O)Cc1c(F)cccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 6/20 0.37
OPRM1 P35372 4/20 0.37
SLC6A2 P23975 4/20 0.37
SLC6A4 P31645 4/20 0.37
MEN1 O00255 3/20 0.37
OPRD1 P41143 3/20 0.37
OPRK1 P41145 3/20 0.37
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
SLC22A1 O15245 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
KDM4E B2RXH2 2/20 0.34
TSHR P16473 2/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375824 0.85 KMT2A (0.39) GAANPC1RAB9AKMT2AOPRM1
SCHEMBL4377558 0.81 OPRM1 (0.38) KMT2AOPRM1SLC6A2SLC6A4MEN1
SCHEMBL10451681 0.81 SLC6A4 (0.45) GAAKMT2AOPRM1SLC6A2SLC6A4
SCHEMBL10451679 0.81 SLC6A4 (0.45) GAAKMT2AOPRM1SLC6A2SLC6A4
SCHEMBL10451711 0.81 SLC6A4 (0.45) GAAKMT2AOPRM1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL10450224 0.80 SLC6A4 (0.44) GAAKMT2AOPRM1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL10450226 0.80 SLC6A4 (0.44) GAAKMT2AOPRM1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL10451848 0.80 SLC6A4 (0.44) GAAKMT2AOPRM1SLC6A2SLC6A4
SCHEMBL4369264 0.77 SMN1; SMN2 (0.42) KMT2AOPRM1SLC6A2SLC6A4MEN1
SCHEMBL4373667 0.77 OPRD1 (0.41) NPC1RAB9AKMT2AOPRM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322592-B2 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2009-06-17 EP claimed
US-7022739-B2 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2006-04-04 US claimed
EP-1322592-B1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP claimed
CN-1466567-A Substituted 1-aminobutan-3-01 derivatives 2004-01-07 CN claimed
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2003-11-20 US claimed
EP-1322592-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP claimed
WO-2002028817-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2002-04-11 WO claimed
EP-1322592-B2 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2009-06-17 EP disclosed
CN-100391933-C Substituted 1-aminobutan-3-01 derivatives GRLENTHAL GMBH (DE) 2008-06-04 CN disclosed
US-7022739-B2 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2006-04-04 US disclosed
EP-1322592-B1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP disclosed
CN-1466567-A Substituted 1-aminobutan-3-01 derivatives 2004-01-07 CN disclosed
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2003-11-20 US disclosed
EP-1322592-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP disclosed
WO-2002028817-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds CYP3A43, UGT1A3, UGT2B7 GAA 457/4885NPC1 93/4885RAB9A 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.